BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2019 4:13:18 AM | Browse: 1053 | Download: 1479
 |
Received |
|
2019-01-08 03:35 |
 |
Peer-Review Started |
|
2019-01-08 07:54 |
 |
To Make the First Decision |
|
2019-01-22 02:29 |
 |
Return for Revision |
|
2019-01-28 00:57 |
 |
Revised |
|
2019-03-19 00:52 |
 |
Second Decision |
|
2019-03-19 09:56 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2019-03-28 04:14 |
 |
Articles in Press |
|
2019-03-28 04:14 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2019-04-29 01:42 |
 |
Publish the Manuscript Online |
|
2019-04-29 04:13 |
ISSN |
1949-8462 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Meta-Analysis |
Article Title |
Who benefits from percutaneous closure of patent foramen ovale vs medical therapy for stroke prevention? In-depth and updated meta-analysis of randomized trials
|
Manuscript Source |
Invited Manuscript |
All Author List |
Khagendra Dahal, Adil Yousuf, Hussam Watti, Brannen Liang, Sharan Sharma, Jharendra Rijal, Pavan Katikaneni, Kalgi Modi, Neeraj Tandon, Michael Azrin and Juyong Lee |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Juyong Lee, MD, PhD, Division of Cardiology, University of Connecticut Health Center, Farmington, CT 06030, United States. jlee@uchc.edu |
Key Words |
Patent foramen ovale; Stroke; Antiplatelet therapy; Anticoagulation; Meta-analysis |
Core Tip |
Closure of patent foramen ovale closure (PFOC) is a treatment modality for patients with stroke. To evaluate the efficacy and safety of PFOC vs medical therapy in different groups of patients presenting with stroke, we performed this meta-analysis of randomized trials following standard techniques. It showed that PFOC, compared to medical therapy reduced the risk of ischemic stroke and the composite outcome of stroke, transient ischemic attack (TIA) and systemic thromboembolism but no difference was observed in the risk of TIA, mortality and major bleeding. PFOC increased the risk of atrial fibrillation. Subgroup analyses showed that PFOC reduced the risk of stroke in males. |
Publish Date |
2019-04-29 04:13 |
Citation |
Dahal K, Yousuf A, Watti H, Liang B, Sharma S, Rijal J, Katikaneni P, Modi K, Tandon N, Azrin M, Lee J. Who benefits from percutaneous closure of patent foramen ovale vs medical therapy for stroke prevention? In-depth and updated meta-analysis of randomized trials. World J Cardiol 2019; 11(4): 126-136 |
URL |
URL: https://www.wjgnet.com/1949-8462/full/v11/i4/126.htm |
DOI |
DOI: https://dx.doi.org/10.4330/wjc.v11.i4.126 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345